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Abstract
Cancer is one of the leading causes of death worldwide. According to GLOBOCAN,
International Agency for Research on Cancer 2012, it is known that breast cancer is
cancer with the highest percentage of new cases, at 43.3%, and percentage death due
to breast cancer by 12.9%. Although the incidence of breast cancer in Asia remains lower
than in North America, Western Europe, and Oceania, the rates have been increasing
rapidly during the past few decades, and Asian countries now account for 40% of breast
cancer cases diagnosed worldwide. Southeast Asian countries have moderate rates for
breast cancer, with a higher incidence of one in Indonesia. Breast cancer morbidity and
mortality increased among Indonesian women. These increased rateswere associated
with higher prevalence of breast cancer risk factors such as hormonal contraceptive
use and age of menarche. The purpose of this study was to determine the correlation
between hormonal contraceptives use and generation of menarche with breast cancer
among women in Indonesia. This study used a systematic review made by PRISMA.
Searching for literature sources through online databases such as Science Direct,
JSTOR, and Proquest, additional records identified through Google Scholar by using
relevant keywords adjusted by inclusion and exclusion criteria. Five studies included
in this review. All studies discussed breast cancer among women in several regions in
Indonesia. There was a significant correlation between hormonal contraceptives use
and age of menarche with breast cancer among women in Indonesia. Women may be
more careful in determining the duration of hormonal contraceptive use and avoiding a
lifestyle that can accelerate menarche.
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1. Introduction
Cancer is one of the leading causes of death worldwide. In 2012, about 8.2 million
deaths caused by the disease. According to the World Health Organization(WHO),
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cancer was one cause of death worldwide and an estimated 84 million people died
from cancer in the period 2005 to 2015 [1].
According to GLOBOCAN, International Agency for Research on Cancer (IARC) 2012,
it is known that breast cancer is cancer with the highest percentage of new cases, at
43.3%, and percentage death due to breast cancer by 12.9% [2]. Breast cancer is a
group of cells abnormally, and multiple growing in breast tissue and is the most common
malignant disease found in the female group [3]. Breast cancer is a malignancy in breast
tissue that can originate from the ductal epithelium or lobules [4].
In America, there are about 92/100.000 women with breast cancer, with 27/100.000
mortality or 18% of deaths found in women [4]. Although the incidence of breast cancer
in Asia remains lower than in North America, Western Europe, and Oceania, rates have
been increasing rapidly during the past few decades, and Asian countries now account
for 40% of breast cancer cases diagnosed worldwide [5]. The incidence of breast cancer
is higher in developed countries, but the mortality is around69% in developing countries
[6]. Southeast Asian countries have moderate rates for breast cancer, with a higher
incidence of one in Indonesia [5].
Breast cancer is one of the most cancer types in Indonesia. Based on pathological
based registration in Indonesia, breast cancer ranks first with a relative frequency of
18.6%. Data of cancer in Indonesia in 2010, according to histopathological data; Cancer
Registration Agency Association of Indonesian Pathology Specialists and Cancer Foun-
dation Indonesia estimated the number of incidence in Indonesia is 12 /100.000 women.
More than 80% of cases are found to be in an advanced stage [4].
Breast cancer morbidity and mortality increased among Indonesian women. In the
Dharmais Cancer Hospital, the number of new cases and death from breast cancer has
risen by four years in a row. In 2010, the number of new cases was 711 cases, 93 cases
of them caused death. In 2011, the number of new cases was 769 cases, 120 cases of
them caused death. In 2012, the number of new cases was 809 cases, 130 cases of them
caused death. And by 2013, the number of new cases was 819.217 cases of them caused
death. [7]. These increased rates associated with higher prevalence of breast cancer
risk factors such as hormonal contraceptive use and age of menarche. This systematic
review was conducted to determine the correlation between hormonal contraceptives
use and generation of menarche with breast cancer among women in Indonesia.
2. Methods
This study used a systematic review made by prisma 2009. Source literature search
began on 10 June 2017 by electronic data based through remote.lib.ui.ac.id/lib.ui.ac.id
website. The author conducted searching on ScienceDirect, JSTOR, and Proquest, addi-
tional records identified throughGoogle Scholar. Keywords are Hormonal Contraception
AND Age of Menarche AND Breast Cancer AND Indonesia. The criteria inclusion in this
study were Indonesian and English language, Indonesia state and the journal year is the
last ten years published, starting from 2007 to 2017. The criteria exclusion criteria are
apart from the inclusion criteria.
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From Science Direct, it’s obtained 12 journals, JSTOR 12 journals, Proquest 91 journals,
and google scholar 1640 memoirs. Journals screen by years 2007-2017 was 850. After
identification conducted initial screening by reading the titles and abstracts, it’s obtained
20 journals, and 838 journals remove because of claim, state, variable and year which
were not appropriate with the topic. In the eligibility phase, eight journals were reviewed
to decide whether the journals could use and authors got five journals systematically for
systematic review.
Figure 1: Systematic Review Flowchart.
3. Results
Five studies included in this review. All studies discuss breast cancer among women in
several regions in Indonesia.
Based on research conducted by Dwi Kartika Rukmi and Rukmi Handayani (2014), risk
factors related to breast cancer according to multivariable analysis were age of menar-
che <12 (OR: 15.84; CI: 1.27-198.29; p= 0.032) and application of hormonal contraceptive
(OR: 3.625; CI: 1.02-12.93; p= 0.040) [8].
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The results of the study of Fitria Prabandari and Dyah Fajarsari (2016) found that
there is a correlation between breast cancer and age of menarche with p-value 0,013
(OR: 21.242; CI: 1.919-235.181) and there is a correlation between breast cancer and the
application of hormonal contraceptive with p-value 0,041 (OR: 12.759; CI: 1,108-146.874)
[9].
Research by Gusti Ayu Triara Dewi and Lucia Yovita Hendrati (2015), the results of
the analysis using binary logistic regression (α= 5%) indicated that the use of hormonal
contraceptive (p= 0.028); OR: 3.266) and age of menarche (p= 0.031; OR: 3.492) has
a significant correlation with the incidence of breast cancer in women at Dr. Soetomo
Hospital [10].
Research by Harianto, Rina Mutiara, and Hery Surachmat (2015) with case-control
research designs found that the use of combination contraception pills has the risk
to have breast cancer 1,864 times compare with them who don’t take that pills [11].
Marice Sihombing and Aprildah Nur Sapardin (2015) on the results of their research
found that one of the dominant risk factors of breast tumor among women was the use
of contraception with p-value 0.002 (OR: 3.63; CI: 1.63-8.10) [12].
4. Discussion
4.1. Correlation between hormonal contraceptives use and
breast cancer
Contraception is one effort that can select to prevent conception and pregnancy. Based
on themethod, contraception divided into simple contraceptives andmodern contracep-
tives. Modern contraception divided into four processes, namely mechanical, hormonal,
chemical, and operative techniques. Hormonal methods of pill, injection, or implant.
Use of hormonal contraceptives can increase the risk of breast cancer. Such hormonal
contraceptives can be pills, combination pills, and mini-pills, injections, or implants or
plants [13]. The risk of breast cancer incidence associated with long-term use of hor-
monal contraception.
The use of oral contraceptives over extended periods causes an increased risk of
breast cancer. The increased risk of breast cancer also occurs in women who use
hormone therapy, such as exogenous hormones. The exogenous hormone can cause
an increased risk of breast cancer. The use of hormonal contraceptives can lead to
increased exposure of the hormone estrogen in the body. There is an increase in
exposure to the hormone estrogen that can trigger abnormal cell growth in certain
parts, such as the breast.
4.2. Correlation between age of menarche and breast cancer
Women who have first menstruation at <12 years of age have a slightly higher risk of
breast cancer than women who have first menstruation >12 years of age. Increased risk
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of breast cancer is due to the duration of estrogen exposure that is longer and slightly
higher.
When a woman experiences her first period, the function of ovarian cycles that pro-
duction of estrogen begins. The longer a woman is exposed, the higher the risk for
breast cancer she gets. In addition to being presented, the regularity of the menstrual
cycle also plays a role. The balance of the period describes the frequency of exposure,
so the faster a woman gets a higher exposure compared to women whose regular
menstruation is slower or has a long menstrual cycle [14].
Menarche age is too early in women, less than 12 years causing exposure to the hor-
mone estrogen in the body to be faster. Estrogen hormone can trigger the growth of cells
in certain parts of the body is not normal. The mechanism of the occurrence of breast
cancer by estrogen exposure is still not known for sure due to estrogen stimulation of
epithelial cell division or because of a cause by estrogen and its metabolites that directly
act as mutagens that can cause cancer cells in the breast [15].
5. Conclusion
There is a significant correlation between hormonal contraceptives use and age of
menarche with breast cancer among women in Indonesia. The longer the duration of
hormonal contraceptive use, the higher the risk of breast cancer. Women who are more
at risk of breast cancer are women with a first menstrual period of fewer than 12 years.
Based on the systematic review, authors have a few suggestions: women may be more
careful in determining the duration of hormonal contraceptive use, avoiding a lifestyle
that can accelerate menarche, need to do early detection regularly with breast self-
examination and then followed by examination mammography every year, and need
understanding of prevention efforts, early diagnosis, curative or palliative treatment and
good rehabilitation efforts.
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